Logo image of ULBI

ULTRALIFE CORP (ULBI) Stock Fundamental Analysis

NASDAQ:ULBI - Nasdaq - US9038991025 - Common Stock - Currency: USD

8.05  -0.38 (-4.51%)

After market: 7.7702 -0.28 (-3.48%)

Fundamental Rating

5

ULBI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 94 industry peers in the Electrical Equipment industry. Both the profitability and the financial health of ULBI get a neutral evaluation. Nothing too spectacular is happening here. ULBI may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make ULBI suitable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ULBI was profitable.
ULBI had a positive operating cash flow in the past year.
In multiple years ULBI reported negative net income over the last 5 years.
ULBI had a positive operating cash flow in 4 of the past 5 years.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.36%, ULBI is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
The Return On Equity of ULBI (3.88%) is better than 76.60% of its industry peers.
The Return On Invested Capital of ULBI (4.34%) is better than 71.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ULBI is significantly below the industry average of 9.87%.
The last Return On Invested Capital (4.34%) for ULBI is above the 3 year average (3.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.36%
ROE 3.88%
ROIC 4.34%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ULBI has a better Profit Margin (3.05%) than 74.47% of its industry peers.
In the last couple of years the Profit Margin of ULBI has declined.
ULBI has a better Operating Margin (6.19%) than 77.66% of its industry peers.
ULBI's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 25.16%, ULBI perfoms like the industry average, outperforming 56.38% of the companies in the same industry.
ULBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.19%
PM (TTM) 3.05%
GM 25.16%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
ULBI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ULBI has more shares outstanding
The debt/assets ratio for ULBI is higher compared to a year ago.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

ULBI has an Altman-Z score of 2.07. This is not the best score and indicates that ULBI is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.07, ULBI is doing good in the industry, outperforming 61.70% of the companies in the same industry.
ULBI has a debt to FCF ratio of 3.04. This is a good value and a sign of high solvency as ULBI would need 3.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.04, ULBI is in the better half of the industry, outperforming 77.66% of the companies in the same industry.
ULBI has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.37, ULBI perfoms like the industry average, outperforming 52.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 3.04
Altman-Z 2.07
ROIC/WACC0.45
WACC9.68%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 3.22 indicates that ULBI has no problem at all paying its short term obligations.
ULBI has a Current ratio of 3.22. This is in the better half of the industry: ULBI outperforms 77.66% of its industry peers.
ULBI has a Quick Ratio of 1.70. This is a normal value and indicates that ULBI is financially healthy and should not expect problems in meeting its short term obligations.
ULBI has a Quick ratio of 1.70. This is in the better half of the industry: ULBI outperforms 64.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.7
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ULBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.28%.
ULBI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.31% yearly.
The Revenue has been growing slightly by 2.74% in the past year.
Measured over the past years, ULBI shows a quite strong growth in Revenue. The Revenue has been growing by 9.02% on average per year.
EPS 1Y (TTM)-51.28%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)2.74%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.03%

3.2 Future

Based on estimates for the next years, ULBI will show a very strong growth in Earnings Per Share. The EPS will grow by 43.60% on average per year.
The Revenue is expected to grow by 18.34% on average over the next years. This is quite good.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.18 indicates a rather expensive valuation of ULBI.
Compared to the rest of the industry, the Price/Earnings ratio of ULBI indicates a somewhat cheap valuation: ULBI is cheaper than 79.79% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ULBI to the average of the S&P500 Index (26.92), we can say ULBI is valued slightly cheaper.
ULBI is valuated reasonably with a Price/Forward Earnings ratio of 8.49.
ULBI's Price/Forward Earnings ratio is rather cheap when compared to the industry. ULBI is cheaper than 93.62% of the companies in the same industry.
ULBI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.46.
Industry RankSector Rank
PE 21.18
Fwd PE 8.49
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ULBI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ULBI is cheaper than 86.17% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 95.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.59
EV/EBITDA 12.12
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ULBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULBI's earnings are expected to grow with 43.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)6.41
EPS Next 2Y43.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ULBI!.
Industry RankSector Rank
Dividend Yield N/A

ULTRALIFE CORP

NASDAQ:ULBI (6/24/2025, 8:02:01 PM)

After market: 7.7702 -0.28 (-3.48%)

8.05

-0.38 (-4.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)07-23 2025-07-23
Inst Owners73.67%
Inst Owner Change-4.88%
Ins Owners3.16%
Ins Owner Change1.44%
Market Cap133.87M
Analysts82.86
Price Target14.28 (77.39%)
Short Float %2.38%
Short Ratio4.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.25%
Min EPS beat(2)-93.46%
Max EPS beat(2)-15.03%
EPS beat(4)1
Avg EPS beat(4)-36.27%
Min EPS beat(4)-93.46%
Max EPS beat(4)54.06%
EPS beat(8)4
Avg EPS beat(8)83.21%
EPS beat(12)6
Avg EPS beat(12)64.09%
EPS beat(16)7
Avg EPS beat(16)37.99%
Revenue beat(2)2
Avg Revenue beat(2)5.56%
Min Revenue beat(2)3.65%
Max Revenue beat(2)7.48%
Revenue beat(4)3
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)7.48%
Revenue beat(8)6
Avg Revenue beat(8)5.23%
Revenue beat(12)8
Avg Revenue beat(12)4.34%
Revenue beat(16)10
Avg Revenue beat(16)3.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.11%
Valuation
Industry RankSector Rank
PE 21.18
Fwd PE 8.49
P/S 0.77
P/FCF 7.59
P/OCF 6.67
P/B 0.98
P/tB 2
EV/EBITDA 12.12
EPS(TTM)0.38
EY4.72%
EPS(NY)0.95
Fwd EY11.78%
FCF(TTM)1.06
FCFY13.17%
OCF(TTM)1.21
OCFY15%
SpS10.42
BVpS8.2
TBVpS4.03
PEG (NY)0.31
PEG (5Y)6.41
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 3.88%
ROCE 5.58%
ROIC 4.34%
ROICexc 4.55%
ROICexgc 7.31%
OM 6.19%
PM (TTM) 3.05%
GM 25.16%
FCFM 10.17%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 3.04
Debt/EBITDA 3.31
Cap/Depr 54.03%
Cap/Sales 1.42%
Interest Coverage 250
Cash Conversion 131.58%
Profit Quality 333.52%
Current Ratio 3.22
Quick Ratio 1.7
Altman-Z 2.07
F-Score3
WACC9.68%
ROIC/WACC0.45
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.28%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-38.1%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.74%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.03%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.72%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1545.08%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y3304.24%
OCF growth 3Y56.62%
OCF growth 5YN/A